Here’s a very helpful article from yesterday’s STAT News about what 23andMe’s genetic reports can and cannot show…. Full Story>
New York Times: F.D.A. Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers
On April 6, the New York Times reports that the FDA will allow 23andMe to sell genetic tests for disease risk to consumers. According to the article, customers have to specifically ask to be tested for Alzheimer’s and Parkinson’s risk.
April is Parkinson’s Awareness Month
Raise awareness of Parkinson’s in April by speaking with your family, friends, and neighbors about it. Contact a local newspaper, radio station, or TV station about how you are coping with Parkinson’s Disease. Start a blog about positive and negative aspects of Parkinson’s — if you are living with it or caring for someone with PD.
EurekAlert! “Journal of Parkinson’s Disease celebrates key breakthroughs”
From the shaking palsy to alpha-synuclein, the stories behind the science from many of the researchers who played key roles in achieving significant milestones are published.
Stanford Movement Disorder Specialist to talk about medications for treating Parkinson’s motor symptoms, in Palo Alto, April 12
James Tetrud, MD, a movement disorder specialist at Stanford, will be talking about medications for treating PD motor symptoms at the Palo Alto Parkinson’s Support Group meeting on Wednesday, April 12th, 2-3:30pm.
- « Previous Page
- 1
- …
- 171
- 172
- 173
- 174
- 175
- …
- 201
- Next Page »